Barbara Bohle, PhD
Center for Physiology and Pathophysiology
We are interested to elucidate the immune mechanisms underlying the induction, maintenance and cure of IgE-mediated allergy and to develop novel concepts for an efficient and safe allergen-specific immunotherapy.
Zulehner, N., B. Nagl, P. Briza, A. Roulias, B. Ballmer-Weber, G. J. Zlabinger, F. Ferreira, and B. Bohle. Characterization of the T cell response to Dau c 1, the Bet v 1-homolog in carrot. Allergy , in press
Kollmann, D., B. Nagl, C. Ebner, W. Emminger, S. Wöhrl, C. Kitzmüller, S. Vrtala, A. Mangold, H.J. Ankersmit, and B. Bohle. The quantity and quality of αα-gal -specific antibodies differs in individuals with and without delayed red meat allergy. Allergy, in press
Subbarayal, B., D. Schiller, C. Möbs, W. Pfützner, B. Jahn-Schmid, B. Gepp, H. Breiteneder, S. Vieths and B. Bohle. The diversity of Bet v 1-specific IgG4 antibodies remains mostly constant during the course of birch pollen immunotherapy. J Allergy and Clin Immunol, S0091-6749(15)00731-9. doi: 10.1016/j.jaci.2015.05.025. 2015
Deifl, S., C. Kitzmüller, P. Steinberger, M. Himly, B. Jahn-Schmid, G. F. Fischer, G.J. Zlabinger, and B. Bohle. Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients. Allergy, 69:1602, doi: 10.1111/all.12524. 2015
Subbarayal, B., D. Schiller, C. Möbs, N.W. de Jong, C. Ebner, N. Reider, D. Bartel, J. Lidholm, W. Pfützner, R. Gerth van Wijk , S. Vieths, and B. Bohle. Kinetics, cross-reactivity and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Allergy, 68:1377, DOI: 10.1111/all.12236. 2013